ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors
Status:
RECRUITING
Trial end date:
2026-01-30
Target enrollment:
Participant gender:
Summary
Alkaline phosphatase (ALP) is a membrane-bound glycoprotein that catalyzes the hydrolysis of phosphates at alkaline pH values. As one of the earliest discovered oncofetal antigens, ALP has emerged as a significant biomarker for various malignant tumors, such as ovarian cancer, breast cancer, trophoblastic tumors, germ cell tumors, endometrial cancer, testicular tumors, cervical intraepithelial neoplasia, and gastrointestinal tumors.